The results showed that anti-PD1 treatment moderately reduced the growth of tumors derived from sh-Ctrl cells, while CMTR1 knockdown further significantly enhanced the inhibition of tumor growth mediated by anti-PD1 treatment (Fig. 6D, E). The gene discussed is CMTR1; the disease is neoplasm.